Application of nanotechnology and micro/nanorobots in thrombotic diseases
Thrombotic diseases, a class of circulatory system disorders characterized by the abnormal coagulation of blood within arterial and venous vessels, leading to partial or complete vascular occlusion, represent a major global cause of mortality and morbidity. Considering the inefficacy of thrombolytic...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | EngMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950489925000077 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849725873030168576 |
|---|---|
| author | Siqi Lv Liang V. Tang Yu Hu |
| author_facet | Siqi Lv Liang V. Tang Yu Hu |
| author_sort | Siqi Lv |
| collection | DOAJ |
| description | Thrombotic diseases, a class of circulatory system disorders characterized by the abnormal coagulation of blood within arterial and venous vessels, leading to partial or complete vascular occlusion, represent a major global cause of mortality and morbidity. Considering the inefficacy of thrombolytic therapies and high incidence of complications, these diseases pose significant healthcare challenges. Nanotechnology, distinguished by its precise targeting, on-demand drug release, reduced dosage, and lower risk of hemorrhagic complications, offers unique advantages for the diagnosis and treatment of thrombotic disorders. As a cutting-edge technology, micro/nanorobots are novel therapeutic options for managing these conditions. This review elucidates the mechanisms of thrombus formation, discusses the efficacy and limitations of traditional antithrombotic drugs, summarizes research advancements in nanomaterials and micro/nanorobots for thrombotic diseases, and presents their promising clinical translation prospects. |
| format | Article |
| id | doaj-art-ff825827a1fe49269b64b9ccc11ea233 |
| institution | DOAJ |
| issn | 2950-4899 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EngMedicine |
| spelling | doaj-art-ff825827a1fe49269b64b9ccc11ea2332025-08-20T03:10:21ZengElsevierEngMedicine2950-48992025-06-012210006110.1016/j.engmed.2025.100061Application of nanotechnology and micro/nanorobots in thrombotic diseasesSiqi Lv0Liang V. Tang1Yu Hu2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Lab of Molecular Biological Targeted Therapies of the Ministry of Education, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Lab of Molecular Biological Targeted Therapies of the Ministry of Education, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Corresponding author. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Lab of Molecular Biological Targeted Therapies of the Ministry of Education, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Corresponding author. Key Lab of Molecular Biological Targeted Therapies of the Ministry of Education, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Thrombotic diseases, a class of circulatory system disorders characterized by the abnormal coagulation of blood within arterial and venous vessels, leading to partial or complete vascular occlusion, represent a major global cause of mortality and morbidity. Considering the inefficacy of thrombolytic therapies and high incidence of complications, these diseases pose significant healthcare challenges. Nanotechnology, distinguished by its precise targeting, on-demand drug release, reduced dosage, and lower risk of hemorrhagic complications, offers unique advantages for the diagnosis and treatment of thrombotic disorders. As a cutting-edge technology, micro/nanorobots are novel therapeutic options for managing these conditions. This review elucidates the mechanisms of thrombus formation, discusses the efficacy and limitations of traditional antithrombotic drugs, summarizes research advancements in nanomaterials and micro/nanorobots for thrombotic diseases, and presents their promising clinical translation prospects.http://www.sciencedirect.com/science/article/pii/S2950489925000077NanoparticleMicro/nanorobotThrombosisTargeting |
| spellingShingle | Siqi Lv Liang V. Tang Yu Hu Application of nanotechnology and micro/nanorobots in thrombotic diseases EngMedicine Nanoparticle Micro/nanorobot Thrombosis Targeting |
| title | Application of nanotechnology and micro/nanorobots in thrombotic diseases |
| title_full | Application of nanotechnology and micro/nanorobots in thrombotic diseases |
| title_fullStr | Application of nanotechnology and micro/nanorobots in thrombotic diseases |
| title_full_unstemmed | Application of nanotechnology and micro/nanorobots in thrombotic diseases |
| title_short | Application of nanotechnology and micro/nanorobots in thrombotic diseases |
| title_sort | application of nanotechnology and micro nanorobots in thrombotic diseases |
| topic | Nanoparticle Micro/nanorobot Thrombosis Targeting |
| url | http://www.sciencedirect.com/science/article/pii/S2950489925000077 |
| work_keys_str_mv | AT siqilv applicationofnanotechnologyandmicronanorobotsinthromboticdiseases AT liangvtang applicationofnanotechnologyandmicronanorobotsinthromboticdiseases AT yuhu applicationofnanotechnologyandmicronanorobotsinthromboticdiseases |